Since 1979, we’ve been digging our planet’s grave and filling it with plastic. Half of the 300 million tons of plastic produced worldwide each year are single-use plastic. Meaning it gets completely thrown away. Plastic made of petroleum doesn’t break down so, it sits in landfills, on our lawns,…

Are you an innovative biotech company that is R&D-intensive and is developing strategic partnerships within the industry? Enter the Buzz of BIO Contest for your chance to win a complimentary Company Presentation that includes registration at the 2020 BIO International Convention. Buzz of BIO…

Since the beginning of time, production of any kind creates waste. From our gadgets, to our personal care, to our food, growth begets garbage. However, as the planet drowns in our own waste, researchers are finding new and creative ways to reuse our refuse. Some of the best biotech innovations on…

On Sunday, February 16th, we celebrate #InnovationDay.  In virtually every technology and industry, innovation is seen as a positive. Eco-friendly cars, personalized medicine, virtual reality, and smart appliances are seen as not only the wave of the future but as necessary to meet the…

Since the earliest days of biotech, the UK and the USA have worked together to move science forward and build globally competitive companies.  James Watson (US) and Francis Crick (UK) worked together to solve the structure of the molecule that underpins the industry. The two technologies on which…

Basically! Aramark, one of the leading food service businesses in the country, released a list of four foodie “megatrends” consumers can look forward to in 2020: plant-forward dishes, sustainability, superfoods, and global dishes. We happened to notice that biotech is a major player across all four…

Day #2 of the BIO CEO & Investor Conference was all about the future. How can we ensure the workforce reflects the diverse demographics of the patients the industry serves? What does the future of biotech investment look like? How can we incentivize innovation? Here are some takeaways from …

Last month, the Biotechnology Innovation Organization (BIO) released the first annual report measuring diversity and inclusion in the biotech industry, with real, practical solutions for making the biotech workforce more representative of the industry’s customers and patients. During the BIO CEO …

We’re seeing an “extraordinary level” of biotech innovation, said BIO Chair Jeremy Levin, CEO of Ovid Therapeutics Inc., while kicking off the 22nd BIO CEO & Investor Conference on February 10th in New York. Day #1 of the conference featured discussions about the breakthrough therapies of the…

“The promise for patients has never been better from a scientific point of view,” said BIO CEO and former Member of Congress Jim Greenwood, speaking at the 22nd BIO CEO & Investor Conference in New York. “But it’s the worst of times politically.” Specifically: There are “mountains of political…